MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Pharmaceutical Economics and Policy
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,682 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,682 works in the cohort · of 4,299,418page 9 of 34

Labels cover 5 of 1,682 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,682 of 1,682 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affvenueaboutunlabeled
A Survey of the Regulatory Requirements for the Acceptance of Foreign Comparator Products by Participating Regulators and Organizations of the International Generic Drug Regulators Programme
Alfredo García‐Arieta, Craig Simon, Gustavo Mendes Lima Santos, Iván Omar Calderón Lojero, Zulema Rodríguez Martínez, Clare Rodrigues +12 more
2019· article· en· Journal of Pharmacy & Pharmaceutical Sciences· Economics, Econometrics and Finance
distilled prediction:candidate · noneconsensus · none
10
citations
affunlabeled
Pharmaceutical Market and Drug Price Policy in India
Venkatanarayana Motkuri, Rudra Narayan Mishra
2020· article· en· Review of Development and Change· Economics, Econometrics and Finance
distilled prediction:candidate · noneconsensus · none
10
citations
affvenueaboutunlabeled
Expensive Drugs for Rare Diseases in Canada: What Value and At What Cost?
Sandra Sirrs, H Anderson, Bashir Jiwani, Larry D. Lynd, Eric Lun, Bob Nakagawa +3 more
2023· review· en· A Nudge Too Far? A Nudge at All? On Paying People to Be Healthy· Economics, Econometrics and Finance
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
10
citations
venueaboutno affno abstractunlabeled
Patient care and health compromised by drug shortages in Canada
Kathie Lynas
2013· article· en· Canadian Pharmacists Journal / Revue des Pharmaciens du Canada· Economics, Econometrics and Finance
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
9
citations
afffundvenueaboutunlabeled
Nonpatentable drugs and the cost of our ignorance
Frédéric Calon
2006· article· en· Canadian Medical Association Journal· Economics, Econometrics and Finance
distilled prediction:candidate · noneconsensus · none
9
citations
affno abstractunlabeled
Improving affordability of new Essential Cancer Medicines
Ellen ‘t Hoen, Salomé Meyer, Patrick Durisch, Wilbert Bannenberg, Katrina Perehudoff, Tim Reed +1 more
2019· article· en· The Lancet Oncology· Economics, Econometrics and Finance
distilled prediction:candidate · insufficient_payloadconsensus · none
9
citations

How this was built: Screen · Findings · About